ATLANTA, Oct. 2, 2017 /PRNewswire/ -- Today the Sterling Institutional Review Board (Sterling IRB) announced its establishment of a new North American Panel to expand Sterling's program of ethical oversight for human subjects research.
"While maintaining a steadfast focus on protecting research participants and regulatory compliance, we aim to streamline the ethical review process with end-to-end solutions," said Ted Green, President and CEO. "The ability to directly oversee research sites in both Canada and the United States while maintaining our commitment to high standards will result in saving time and money for our clients."
Sterling IRB has helped lead the way in safeguarding the rights and welfare of clinical research participants for more than 25 years. As part of the company's commitment to streamline processes, Sterling IRB provides a single-point-of-contact that focuses on clients' specific needs. Headquartered in Atlanta, Georgia, the company's clients include pharmaceutical and biotechnology companies, clinical research organizations (CROs), research institutions, hospitals, federal agencies and individual investigators.
For more information, contact:
SOURCE Sterling IRB